Theratechnologies develops therapies for unmet medical needs in commercially attractive specialty markets.
Theratechnologies (TSX: TH) is a Canadian biopharmaceutical company with core expertise in peptide-based therapeutics. Its most advanced compound, tesamorelin, is an analogue of the human growth hormone releasing factor.
In the clinic
Tesamorelin: Completed Phase 3 clinical studies evaluating tesamorelin in HIV-associated lipodystrophy.
Products
Our lead product: tesamorelin
A New Drug Application was filed with the U.S. Food and Drug Administration in order to obtain market approval for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy.